1. Home
  2. CYN vs VNRX Comparison

CYN vs VNRX Comparison

Compare CYN & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cyngn Inc.

CYN

Cyngn Inc.

HOLD

Current Price

$1.12

Market Cap

22.9M

Sector

Technology

ML Signal

HOLD

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.55

Market Cap

24.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYN
VNRX
Founded
2013
N/A
Country
United States
United States
Employees
62
N/A
Industry
EDP Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.9M
24.5M
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
CYN
VNRX
Price
$1.12
$0.55
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$1.67
AVG Volume (30 Days)
141.2K
539.7K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.00
EPS
N/A
N/A
Revenue
$368,138.00
$1,727,384.00
Revenue This Year
$3,359.28
$355.66
Revenue Next Year
$347.47
$849.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40.04
52 Week Low
$1.03
$0.13
52 Week High
$6.82
$3.26

Technical Indicators

Market Signals
Indicator
CYN
VNRX
Relative Strength Index (RSI) 46.09 22.24
Support Level $1.07 $0.19
Resistance Level $1.40 $0.91
Average True Range (ATR) 0.07 0.10
MACD 0.01 -0.00
Stochastic Oscillator 36.00 0.07

Price Performance

Historical Comparison
CYN
VNRX

About CYN Cyngn Inc.

Cyngn Inc is an industrial autonomous vehicle technology company, focused on addressing industrial uses for autonomous vehicles. It develops full-stack autonomous driving software, DriveMod, which is integrated into vehicles manufactured by original equipment manufacturers during the assembly process. The company designs its software to be compatible with a range of sensors and hardware components and integrates it with its own systems to enable autonomous vehicle functionality.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.

Share on Social Networks: